Communications Service Tender Manchester

Communications Service Tender Manchester

The West Midlands Academic Health Science Network is one of 15 national AHSNs established in 2013 to cover the NHS in England.

United Kingdom-Birmingham: Advertising and marketing services

2019/S 195-474070

Contract notice

Services

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

University Hospitals Birmingham NHS Foundation Trust
Mindelsohn Way
Birmingham
B15 2WB
United Kingdom
Telephone: +44 1213712000
E-mail: Nita.Vryaparj@uhb.nhs.uk
NUTS code: UK
Internet address(es):Main address: https://www.uhb.nhs.uk/home.htm

I.2)Information about joint procurement

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: https://nhs.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://nhs.bravosolution.co.uk
Tenders or requests to participate must be submitted to the abovementioned address

I.4)Type of the contracting authority

Body governed by public law

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

Provision of a Communications Service

Reference number: PROC.160024

II.1.2)Main CPV code

79340000

II.1.3)Type of contract

Services

II.1.4)Short description:

The West Midlands Academic Health Science Network (WMAHSN) is one of 15 national AHSNs established in 2013 to cover the NHS in England. In its first 6 years WMAHSN has developed into the regions primary agency for driving the adoption and spread of healthcare innovation. WMAHSN is hosted by University Hospitals of Birmingham (UHB). The AHSN has 6 primary workstreams geared towards supporting the adoption and uptake of innovations which deliver clear patient and system benefits.

— innovation adoption – driving the adoption of 22 ground breaking innovations in over 30 healthcare sites across the region. Over 30 000 patients are benefiting from these new innovations which range from medical devices to medicines and new pathways.

— WM patient safety collaborative – improving safety through best practice to reduce patient harm across a number of settings including pharmacy, maternity, GP and care homes,

— genomics and precision medicine – delivering the 100 000 genome project and regional.

II.1.5)Estimated total value

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)

II.2.3)Place of performance

NUTS code: UK

II.2.4)Description of the procurement:

Services

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 48
This contract is subject to renewal: no

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
III.1.2)Economic and financial standing
III.1.3)Technical and professional ability
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.1)Information about a particular profession
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 08/11/2019
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 03/01/2020

IV.2.7)Conditions for opening of tenders

Date: 11/11/2019
Local time: 12:00

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no
VI.2)Information about electronic workflows
VI.3)Additional information:
VI.4)Procedures for review

VI.4.1)Review body

University Hospitals Birmingham
Institute of Translational Medicine
Birmingham
B15 2TH
United Kingdom
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

07/10/2019

Enjoyed this post? Share it!